Active Pharmaceutical Ingredients and Intermediates Catalog

Regulatory Submission
Select all that apply

Ready to move from idea to impact?

Whether you’re seeking additional information about a specific API or interested in making a purchase, our sales team can help.

Curia makes no representation, guarantee, or warranty as to the completeness or accuracy of the information in this catalog or to the patentability of these products or defenses from third party intellectual property right infringement actions. This catalog is for informational purposes only and is not an offer for sale. Nothing in this catalog should be considered as a promotion or advertisement for the sale or use of any product where the sale or use of the product infringes any valid patents or is not permitted under applicable laws and regulations.

API name

Site

Regulatory submission

There are no matches within your selected filters. Can’t find what you’re looking for? Contact us.

A

Alcaftadine

Site

Valladolid, Spain

Regulatory submission

US DMF, Korea

Alclometasone-17,21- Dipropionate

Site

Valladolid, Spain

Regulatory submission

US DMF, Japan DMF

Altrenogest

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF

Amphetamine Aspartate Monohydrate Milled

Site

Rensselaer, US

Regulatory submission

US DMF

Amphetamine Sulfate

Site

Rensselaer, US

Regulatory submission

US DMF

Argatroban

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, EU DMF

Azelastine HCl

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, EU DMF

Aztreonam (not sterile)

Site

Rozzano Valleambrosia, Italy

Regulatory submission

US DMF

Aztreonam Sterile

Site

Tonneins, France

Regulatory submission

-

B

Bamifylline HCl

Site

Bon Encontre, France

Regulatory submission

EU DMF

Beclomethasone-17,21- Dipropionate

Site

Valladolid, Spain

Regulatory submission

CEP, Russia

Beclomethasone-17,21- Dipropionate Monohydrate

Site

Valladolid, Spain

Regulatory submission

-

Betametasone-17,21- Dipropionate Sterile

Site

Valladolid, Spain

Regulatory submission

EU DMF

Betamethasone Acetate

Site

Valladolid, Spain

Regulatory submission

-

Betamethasone Base

Site

Valladolid, Spain

Regulatory submission

-

Betamethasone Benzoate

Site

Valladolid, Spain

Regulatory submission

-

Betamethasone Butyrate Propionate

Site

Valladolid, Spain

Regulatory submission

Japan DMF

Betamethasone Valerate Acetate

Site

Valladolid, Spain

Regulatory submission

-

Betamethasone-17- Valerate

Site

Valladolid, Spain

Regulatory submission

CEP, Japan DMF, Russia

Betamethasone-17,21- Dipropionate

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP, Japan DMF, China

Betamethasone-21- Phosphate Disodium Salt

Site

Valladolid, Spain

Regulatory submission

CEP, Japan DMF, Russia

Brexanalone

Site

Valladolid, Spain

Regulatory submission

US DMF

Bromocriptine Mesylate

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, CEP, India, China, Russia

Budesonide

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP, China, Russia

Budesonide Sterile

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP, China

C

Carbimazole

Site

Bon Encontre, France

Regulatory submission

EU DMF

Chlorthalidone

Site

Origgio, Italy

Regulatory submission

US DMF, CEP, India

Cibenzoline Succinate

Site

Bon Encontre, France

Regulatory submission

EU DMF

Clobetasol-17-Propionate

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP, Japan DMF, Korea

Cyclofenil

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

Japan DMF

Cyclosporine

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, CEP, Japan DMF, Korea

Cyproterone Acetate

Site

Valladolid, Spain

Regulatory submission

CEP

D

Deflazacort

Site

Valladolid, Spain

Regulatory submission

EU DMF

Deoxycholic Acid

Site

Valladolid, Spain

Regulatory submission

US DMF

Desogestrel

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

CEP, EU DMF, Russia

Dexamethasone Acetate

Site

Valladolid, Spain

Regulatory submission

-

Dexamethasone Base

Site

Valladolid, Spain

Regulatory submission

Japan DMF, Korea

Dexamethasone-17- Valerate

Site

Valladolid, Spain

Regulatory submission

Japan DMF

Dexamethasone-17,21- Dipropionate

Site

Valladolid, Spain

Regulatory submission

Japan DMF

Dexamethasone-21- Isonicotinate

Site

Valladolid, Spain

Regulatory submission

CEP, EU DMF

Dexamethasone-21- Phosphate Disodium Salt

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP

Dexmethylphenidate HCl

Site

Springfield, US

Regulatory submission

US DMF

Dextroamphetamine Saccharate

Site

Rensselaer, US

Regulatory submission

US DMF

Dextroamphetamine Sulfate

Site

Rensselaer, US

Regulatory submission

US DMF

Diatrizoate Meglumine

Site

Rensselaer, US

Regulatory submission

US DMF

Diatrizoate Sodium

Site

Rensselaer, US

Regulatory submission

US DMF

Diethylamine Salicylate

Site

Bon Encontre, France

Regulatory submission

EU DMF

Dihydroergocriptine Mesylate

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

EU DMF

Dihydroergocristine Mesylate

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

CEP

Dihydroergotamine Mesylate

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, CEP, Japan DMF

Dorzolamide

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP, Japan DMF

E

Ergotamine Tartrate

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, CEP

Ethanolamine Oleate in Solution

Site

Grafton, US

Regulatory submission

US DMF

Etonogestrel

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF

Exemestane

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP

F

Finasteride

Site

Valladolid, Spain

Regulatory submission

CEP, Korea

Fludrocortisone-21- Acetate

Site

Valladolid, Spain

Regulatory submission

US DMF

Flugestone Acetate

Site

Valladolid, Spain

Regulatory submission

EU DMF

Fluorometholone Base

Site

Valladolid, Spain

Regulatory submission

US DMF

Flutamide

Site

Origgio, Italy

Regulatory submission

US DMF, CEP, India, Russia

Fluticasone-17- Propionate

Site

Valladolid, Spain

Regulatory submission

CEP

Furosemide

Site

Aurangabad, India

Regulatory submission

US DMF, CEP, EU DMF, China

H

Hexetidine (Gexetidine in Russia)

Site

Bon Encontre, France

Regulatory submission

CEP, Russia

Hydrocortisone Aceponate

Site

Valladolid, Spain

Regulatory submission

EU DMF

Hydrocortisone Aceponate Sterile

Site

Valladolid, Spain

Regulatory submission

-

Hydrocortisone Acetate

Site

Valladolid, Spain

Regulatory submission

CEP, Russia

Hydrocortisone Base

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF

Hydrocortisone Sodium Phosphate Sterile

Site

Valladolid, Spain

Regulatory submission

EU DMF

Hydrocortisone-17-Butyrate

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF, Japan DMF

Hydrocortisone-21- Hemisuccinate

Site

Valladolid, Spain

Regulatory submission

CEP, EU DMF

Hydrocortisone-21- Phosphate Disodium Salt

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF, Japan DMF

Hydrocortisone-21- Sodium Succinate Sterile

Site

Valladolid, Spain

Regulatory submission

EU DMF, India

Hydroxyethyl Salicylate

Site

Bon Encontre, France

Regulatory submission

EU DMF

I

Isosorbide Mononitrate

Site

Aurangabad, India

Regulatory submission

CEP

L

Levocabastine

Site

Valladolid, Spain

Regulatory submission

CEP

Loteprednol Etabonate

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF, China

Loteprednol Etabonate Sterile Micronized

Site

Valladolid, Spain

Regulatory submission

US DMF, China

M

Mafenide Acetate

Site

Rensselaer, US

Regulatory submission

US DMF

Medrogestone

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

EU DMF

Medroxyprogesterone Acetate

Site

Valladolid, Spain

Regulatory submission

-

Medroxyprogesterone Acetate Sterile

Site

Valladolid, Spain

Regulatory submission

US DMF

Melengestrol Acetate

Site

Valladolid, Spain

Regulatory submission

US DMF

Meperidine HCl

Site

Rensselaer, US

Regulatory submission

US DMF

Methylphenidate HCl

Site

Springfield, US

Regulatory submission

US DMF

Methylprednisolone Aceponate

Site

Valladolid, Spain

Regulatory submission

EU DMF

Methylprednisolone Hydrogen Succinate

Site

Valladolid, Spain

Regulatory submission

EU DMF

Methylprednisolone-21- Acetate

Site

Valladolid, Spain

Regulatory submission

US DMF

Methylprednisolone-21- Acetate Sterile

Site

Valladolid, Spain

Regulatory submission

US DMF

Methylprednisolone-21- Sodium Succinate Sterile

Site

Valladolid, Spain

Regulatory submission

India

Mifepristone

Site

Valladolid, Spain

Regulatory submission

EU DMF, Japan DMF

Minocycline HCl

Site

Origgio, Italy

Regulatory submission

US DMF, CEP, Japan DMF, India, China, Russia

Mometasone-17-Furoate (Anhydrous)

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP, Japan DMF

Morniflumate

Site

Bon Encontre, France

Regulatory submission

EU DMF

N

Niflumic Acid

Site

Bon Encontre, France

Regulatory submission

CEP

Nifuratel

Site

Bon Encontre, France

Regulatory submission

EU DMF, China, Russia

Norepinephrine Bitartrate

Site

Rensselaer, US

Regulatory submission

US DMF

O

Olopatadine

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF, China

Oxandrolone

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, EU DMF

P

Paliperidone Palmitate Micronized Sterile

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF, China

Pancuronium Bromide

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, CEP

Pralidoxime Chloride

Site

Rensselaer, US

Regulatory submission

US DMF

Pramipexol

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP

Prednicarbate

Site

Valladolid, Spain

Regulatory submission

EU DMF

Prednisolone-21-Phosphate Disodium Salt

Site

Valladolid, Spain

Regulatory submission

US DMF, Japan DMF, India

Prednisone Base

Site

Valladolid, Spain

Regulatory submission

US DMF

Propacetamol HCl Sterile

Site

Bon Encontre, France

Regulatory submission

-

R

Racepinephrine HCl

Site

Rensselaer, US

Regulatory submission

US DMF

Regadenoson

Site

Springfield, US

Regulatory submission

US DMF

Ribavirin

Site

Origgio, Italy

Regulatory submission

US DMF, CEP, India

Rocuronium Bromide

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, CEP, Russia

S

Sirolimus

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, EU DMF, China

Sodium Oxybate

Site

Springfield, US

Regulatory submission

US DMF

T

Tamsulosin

Site

Valladolid, Spain

Regulatory submission

EU DMF

Tapentadol

Site

Springfield, US

Regulatory submission

US DMF

Testosterone Base

Site

Valladolid, Spain

Regulatory submission

US DMF, CEP

Testosterone Cypionate

Site

Valladolid, Spain

Regulatory submission

US DMF

Testosterone Propionate

Site

Valladolid, Spain

Regulatory submission

-

Triamcinolone Acetonide

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF, Japan DMF, India

Triamcinolone Acetonide Sterile

Site

Valladolid, Spain

Regulatory submission

US DMF, EU DMF, Japan DMF, Korea

Triamcinolone Acetonide-21-Phosphate Potassium Salt

Site

Valladolid, Spain

Regulatory submission

EU DMF

Trientine HCl

Site

Rensselaer, US

Regulatory submission

US DMF

Tyloxapol

Site

Rensselaer, US

Regulatory submission

US DMF

V

Vecuronium Bromide

Site

Rozzano Quinto de Stampi, Italy

Regulatory submission

US DMF, EU DMF, Japan DMF, China

Curia makes no representation, guarantee, or warranty as to the completeness or accuracy of the information in this catalog or to the patentability of these products or defenses from third party intellectual property right infringement actions. This catalog is for informational purposes only and is not an offer for sale. Nothing in this catalog should be considered as a promotion or advertisement for the sale or use of any product where the sale or use of the product infringes any valid patents or is not permitted under applicable laws and regulations.

This presentation regarding the potential development and manufacture of API and/or drug product (“Product”) is for informational purposes only. Curia makes no warranties of any kind, express or implied, including but not limited to any warranty of merchantabilities, fitness for a specific purpose, or non-infringement of any intellectual property rights, with respect to the Product or any information or process contained in or related to this presentation. In no event shall this presentation be deemed an offer for the sale of a Product, or an inducement for Curia’s customer to develop the Product or to infringe any third party intellectual property rights. Any decision to enter into a business relationship with Curia regarding the Product or otherwise seek to develop the Product is is solely that of Curia’s customer. Any business relationship between Curia and the customer with respect to the Product shall be documented in a separate written agreement, containing terms and conditions consistent with industry-standard for similar business relations, including but not limited to indemnification by the customer of Curia for any third party claims related to the development or sale of the Product. This presentation is the confidential information of Curia.

Any “Innovator” referenced in this presentation is a separate company from Curia and its affiliates. Any “Brand” name and trademark referenced in this presentation is owned by the corresponding Innovator or its affiliate, and Curia makes no claim of ownership or license to such names or trademarks.

Products with existing patent protection are intended for development use and Regulatory Purposes only, under 35 U.S.C. 271(e)(1) and article 10.6 of the Directive 2001/EC as amended by the Directive 2004/27/EC.

Ready to move from idea to impact?